16154-61-3 Usage
Piperazine derivative
A chemical compound derived from piperazine, which is a heterocyclic organic compound structurally similar to azepine.
Substituted phenyl ring
A benzene ring (six carbon atoms forming a ring with alternating single and double bonds) with one or more atoms or groups of atoms attached to it, in this case, a nitro group and a methyl group.
Nitro group
A functional group (-NO2) consisting of an oxygen-nitrogen-oxygen structure, which is known to impart various chemical properties and reactivity to the compound.
Methyl group
A functional group (-CH3) consisting of one carbon atom bonded to three hydrogen atoms, contributing to the structure and properties of the compound.
Intermediate or building block
The compound is commonly used as a starting material or a precursor in the synthesis of more complex pharmaceuticals and agrochemicals.
Biological activities
1-Methyl-4-(3-Methyl-4-nitrophenyl)piperazine has been studied for its potential antifungal and antimicrobial properties, which could be useful in the development of new drugs or treatments.
New material development
The compound has been investigated as a potential ingredient in the development of new materials for various applications, showcasing its versatility and importance in the field of chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 16154-61-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,1,5 and 4 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 16154-61:
(7*1)+(6*6)+(5*1)+(4*5)+(3*4)+(2*6)+(1*1)=93
93 % 10 = 3
So 16154-61-3 is a valid CAS Registry Number.
16154-61-3Relevant articles and documents
INDOLINONE COMPOUNDS FOR USE AS MAP4K1 INHIBITORS
-
Page/Page column 67; 70, (2020/05/15)
The present disclosure is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein ring A, ring C, X1, X2, L1, R1, R2, R3, R4, R5, R6, R7, m and n are as defined herein, which are useful as MAP4K1 inhibitors, processes for their preparation, pharmaceutical compositions comprising the compounds, and the use of the compounds or the compositions in the treatment or prevention of various diseases, conditions and/or disorders mediated by MAP4K1.
AMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF
-
Paragraph 000229; 000285; 000288, (2021/01/22)
Described herein are compounds that are inhibitors of autophagy and their use in the treatment of disorders such as cancers.
(5,6-DIHYDRO)PYRIMIDO[4,5-E]INDOLIZINES
-
Page/Page column 27, (2015/11/17)
The invention relates to a compound of Formula (I) wherein, R1 and R2 independently are selected from the group consisting of optionally substituted (6-10C)aryl and (1-5C)heteroaryl groups. The compounds can be used in pharmaceutical compositions, in particular in the treatment of cancer.
